In the literature, the Acetatifactor genus has been described to activate the bile acid membrane receptor TGR4 and, in this way, stimulate GLP-1 secretion, which improves obesity [39] and, consequently, liver function and tolerance to insulin and glucose [40]. The gene discussed is GPBAR1; the disease is obesity disorder.